HONG KONG and FT. LAUDERDALE, Fla., April 14 /PRNewswire/ -- OrbusNeich Medical, Inc. (the “Company”), a designer, developer, manufacturer and marketer of innovative medical devices for the treatment of cardiovascular diseases, today announced that on March 23, 2010, the Company was granted U.S. Patent No. 7,682,384 B2, entitled “Stent with Helical Elements.” The patent relates to an expandable stent comprised of a plurality of helical segments. The Company noted that it has identified unlicensed use by Boston Scientific Corporation of certain technologies protected under U.S. Patent No. 7,682,384 B2.
“OrbusNeich is pleased to have been awarded this valuable patent, which further recognizes the innovativeness of the Company in stent design,” said Al Novak, President and Chief Executive Officer of OrbusNeich. “We are committed to taking all appropriate actions to ensure that our proprietary technology and extensive research and development efforts are to the benefit of OrbusNeich’s investors, employees and physician customers and their patients - not those of competitors.”
OrbusNeich is a global company that designs, develops, manufactures and markets innovative medical devices for the treatment of cardiovascular diseases. Current products are the world’s first pro-healing stent, the Genous Bio-engineered R stent(TM), as well as stents, balloons and guiding catheters marketed under the names of R stent(TM), Scoreflex(TM), SafeCut(TM), Sapphire(TM), Sapphire NC Avita(TM), Avita HP and Lumina(TM).
OrbusNeich Medical, Inc.
